FR2931676B1 - Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains - Google Patents

Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains

Info

Publication number
FR2931676B1
FR2931676B1 FR0802989A FR0802989A FR2931676B1 FR 2931676 B1 FR2931676 B1 FR 2931676B1 FR 0802989 A FR0802989 A FR 0802989A FR 0802989 A FR0802989 A FR 0802989A FR 2931676 B1 FR2931676 B1 FR 2931676B1
Authority
FR
France
Prior art keywords
administration
mixture
treatment
fatty acids
human mammals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0802989A
Other languages
English (en)
Other versions
FR2931676A1 (fr
Inventor
Marie-Laure Loubiere
Benedicte Deminiere
Sandrine Lacoste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ceva Sante Animale SA
Original Assignee
Ceva Sante Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale SA filed Critical Ceva Sante Animale SA
Priority to FR0802989A priority Critical patent/FR2931676B1/fr
Priority to US12/995,216 priority patent/US8933126B2/en
Priority to PCT/EP2009/056679 priority patent/WO2009144321A1/fr
Priority to GB1020206.7A priority patent/GB2483732B/en
Publication of FR2931676A1 publication Critical patent/FR2931676A1/fr
Application granted granted Critical
Publication of FR2931676B1 publication Critical patent/FR2931676B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0802989A 2008-05-30 2008-05-30 Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains Active FR2931676B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0802989A FR2931676B1 (fr) 2008-05-30 2008-05-30 Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
US12/995,216 US8933126B2 (en) 2008-05-30 2009-05-29 Methods of administering a mixture of fatty acids for the treatment of non-human mammals
PCT/EP2009/056679 WO2009144321A1 (fr) 2008-05-30 2009-05-29 Nouveaux modes d'administration d'un mélange d'acides gras pour le traitement de mammifères non humains
GB1020206.7A GB2483732B (en) 2008-05-30 2009-05-29 Novel methods of administering a mixture of fatty acids for the treatment of non-human mammals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0802989A FR2931676B1 (fr) 2008-05-30 2008-05-30 Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains

Publications (2)

Publication Number Publication Date
FR2931676A1 FR2931676A1 (fr) 2009-12-04
FR2931676B1 true FR2931676B1 (fr) 2011-01-14

Family

ID=40202894

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0802989A Active FR2931676B1 (fr) 2008-05-30 2008-05-30 Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains

Country Status (4)

Country Link
US (1) US8933126B2 (fr)
FR (1) FR2931676B1 (fr)
GB (1) GB2483732B (fr)
WO (1) WO2009144321A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314018B2 (en) * 2012-06-25 2016-04-19 Institut de Recherche en Semiochimie et Ethologie Appliquee Feline scratch marking semiochemicals
WO2015110977A1 (fr) * 2014-01-22 2015-07-30 Rolexi Marketing (Pty) Ltd Composition d'acides gras et utilisation médicinale de celle-ci
CN114732810A (zh) 2014-03-18 2022-07-12 信息化学与应用动物行为学研究院 猫安抚信息素
ES2803076T3 (es) * 2014-03-18 2021-01-22 Institut De Rech En Semiochimie Et Ethologie Appliquee Composiciones semioquímicas para reducir los conflictos sociales con los gatos
FR3031039B1 (fr) 2014-12-24 2018-03-02 Virbac Composition apaisante pour animaux comprenant au moins un acide gras et de la nepetalactone
FR3031104B1 (fr) 2014-12-26 2017-01-06 Melchior Mat And Life Science France Composition pro-pheromonale apaisante pour les mammiferes
US11203033B2 (en) 2017-09-19 2021-12-21 Bio Creative Enterprises Essential oil diffuser
KR20200075815A (ko) 2017-10-23 2020-06-26 에피트래커, 인코포레이티드 지방산 유사체 및 대사 증후군 관련 병태 치료에서의 그의 용도
EP3796976A4 (fr) 2018-05-23 2022-03-30 Epitracker, Inc. Compositions et méthodes pour le diagnostic et le traitement d'affections liées à la longévité et à la qualité du vieillissement
US11883513B2 (en) * 2019-12-10 2024-01-30 The Procter & Gamble Company Hair strengthening composition
EP4199751A1 (fr) * 2020-08-20 2023-06-28 Epitracker, Inc. Compositions et méthodes d'amélioration de l'humeur
FR3117731A1 (fr) 2020-12-21 2022-06-24 Virbac Dispositifs portables pour animaux de compagnie avec diffusion passive de compositions sémiochimiques
CN112826846A (zh) * 2020-12-31 2021-05-25 武汉研欣生物科技有限公司 猫用安抚信息素及其制备方法与应用
FR3119315B1 (fr) 2021-02-02 2022-12-30 Virbac « gel diffuseur de pheromones »

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2071497A (en) * 1980-02-02 1981-09-23 Globol Werk Device for vaporising volatile substances
US4804821A (en) * 1986-06-24 1989-02-14 Environmental Fragrance Technologies, Ltd. Aroma diffuser assembly
GB2252907A (en) * 1991-01-30 1992-08-26 Steven James Bradbury Therapeutic aroma diffuser
DE69512509T2 (de) * 1995-02-03 2000-05-31 Fideline Le Rieu Neuf Eigenschaften von Gesichtpheromonen von Katzen
US5805768A (en) * 1996-07-08 1998-09-08 Bunny Moon Enterprises Aroma therapy diffuser
CA2227706C (fr) * 1998-01-21 2010-08-03 Patrick Pageat Pheromones d'apaisement pour diminuer le stress, l'anxiete et l'agressivite de porcs
FR2795960B1 (fr) * 1999-07-05 2001-10-19 Sanofi Elf Microemulsions stables pour l'administration d'acides gras a l'homme ou a l'animal, et utilisation de ces microemulsions
US7252805B2 (en) * 2001-07-14 2007-08-07 Givaudan Sa Device for vaporising and diffusing oils
US20040033067A1 (en) * 2002-08-16 2004-02-19 He Mengtao Pete Methods and apparatus for a controllable vapor-dispensing device

Also Published As

Publication number Publication date
GB201020206D0 (en) 2011-01-12
US8933126B2 (en) 2015-01-13
GB2483732B (en) 2013-02-20
WO2009144321A1 (fr) 2009-12-03
US20110077301A1 (en) 2011-03-31
FR2931676A1 (fr) 2009-12-04
GB2483732A (en) 2012-03-21

Similar Documents

Publication Publication Date Title
FR2931676B1 (fr) Nouveaux modes d'administration d'un melange d'acides gras pour le traitement de mammiferes non humains
ZA201303962B (en) Polyunsaturated fatty acids for the treatment of diseases related to cardiovascular, metabolic and inflammatory disease areas
PH12012500765A1 (en) Boronic acids and esters as inhibitors of fatty acid amide hydrolase
TW201129539A (en) Asymmetric cyclic diester compounds
FR2891838B1 (fr) Procede de preparation d'esters d'acides gras d'origine naturelle fonctionnalises par oxydation utilisables comme fluxants pour bitume
WO2012015758A3 (fr) Méthodes de traitement de la douleur
FR2898356B1 (fr) Diesters d'acides carboxylique ramifies
ZA201003164B (en) Methods of denitrogenating diesel fuel
HK1115373A1 (en) Intermolecular compound of fatty acid triglyceride
PL2219738T3 (pl) Ciekłe czyszczące kompozycje zawierające produkt tłuszczowego acyloizetionianu stabilizowane mieszaniną długołańcuchowych i krótkołańcuchowych kwasów tłuszczowych/mydeł tłuszczowych
EA201100863A1 (ru) Фармацевтическая композиция, включающая диклофенак и сложный эфир гидроксижирной кислоты и полиоксиалкилена
WO2011066544A3 (fr) Composés deutériés utiles pour le traitement de maladies neurodégénératives
ZA200906226B (en) Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
IL213354A (en) Alpha-monoclonal fatty acid alpha history for use as a drug
EP2236137A4 (fr) Composition pharmaceutique pour le traitement de stéatoses hépatiques
WO2012145737A8 (fr) Inhibiteurs de l'hydrolase d'amide d'acide gras (faah) pour administrer un traitement
FR2939667B1 (fr) Composition d'immunoglobine g comme medicament pour le traitement de l'ictere neonatal par incompatibilite foetomaternelle dans le systeme abo
PT2358851E (pt) Utilização de ácido metanossulfónico para a preparação de ésteres de ácidos gordos
IT1395355B1 (it) Procedimento per la preparazione di una miscela bituminosa ad elevata lavorabilita'
WO2011143271A3 (fr) Liposomes thérapeutiques et leurs procédés de production et d'utilisation
DE112008002783A5 (de) Flüssiger Biokraftstoff aus Estern und gebundenen Glyceriden sowie Verfahren zur Herstellung desselben
HUP0600101A2 (en) Resolution process for the preparation of cyclic beta-amino acids esters there of
EP2255675A3 (fr) Procédé d'obtention de foie gras comprenant l'administration de bactéries probiotiques
FR2978916B1 (fr) Composition pharmaceutique solide pour administration buccale d'agomelatine
FR2965177B1 (fr) Procede de traitement des matieres keratiniques a partir d'une composition cosmetique congelee riche en corps gras liquide

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17